Truist Financial Trims Celsius (NASDAQ:CELH) Target Price to $45.00

Celsius (NASDAQ:CELH) had its price objective cut by Truist Financial from $60.00 to $45.00 in a report released on Friday, Benzinga reports. They currently have a hold rating on the stock.

Several other equities research analysts have also recently weighed in on CELH. UBS Group reduced their target price on shares of Celsius from $70.00 to $64.00 and set a buy rating for the company in a research note on Wednesday, August 7th. BNP Paribas assumed coverage on Celsius in a research report on Monday, June 24th. They set an outperform rating and a $87.00 price objective on the stock. TD Cowen cut their target price on Celsius from $68.00 to $50.00 and set a buy rating for the company in a research note on Wednesday, August 7th. Maxim Group decreased their price target on shares of Celsius from $90.00 to $65.00 and set a buy rating on the stock in a research note on Wednesday, August 7th. Finally, Roth Mkm dropped their price objective on shares of Celsius from $75.00 to $65.00 and set a buy rating for the company in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $64.79.

Celsius Stock Down 0.1 %

Shares of NASDAQ CELH opened at $38.03 on Friday. Celsius has a 12 month low of $36.17 and a 12 month high of $99.62. The company has a market cap of $8.86 billion, a P/E ratio of 41.79, a P/E/G ratio of 1.38 and a beta of 1.90. The business’s 50 day moving average is $55.44 and its two-hundred day moving average is $69.22.

Celsius (NASDAQ:CELH) last announced its earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.05. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The business had revenue of $402.00 million for the quarter, compared to analyst estimates of $391.07 million. During the same quarter in the previous year, the firm posted $0.17 earnings per share. Celsius’s revenue was up 23.4% compared to the same quarter last year. Sell-side analysts expect that Celsius will post 1.05 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, major shareholder William H. Milmoe sold 40,000 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $92.95, for a total value of $3,718,000.00. Following the transaction, the insider now directly owns 226,245 shares of the company’s stock, valued at approximately $21,029,472.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Celsius

Several institutional investors have recently bought and sold shares of the business. FinTrust Capital Advisors LLC bought a new position in shares of Celsius in the first quarter valued at about $25,000. EverSource Wealth Advisors LLC raised its stake in shares of Celsius by 3,116.7% in the first quarter. EverSource Wealth Advisors LLC now owns 386 shares of the company’s stock worth $32,000 after acquiring an additional 374 shares during the last quarter. Rise Advisors LLC lifted its position in shares of Celsius by 1,370.0% during the first quarter. Rise Advisors LLC now owns 441 shares of the company’s stock worth $37,000 after purchasing an additional 411 shares in the last quarter. Transcendent Capital Group LLC bought a new stake in shares of Celsius during the fourth quarter valued at approximately $25,000. Finally, Beacon Capital Management LLC acquired a new stake in shares of Celsius in the first quarter valued at approximately $40,000. Institutional investors own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.